EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia

Mohammadreza Khosravifarsani, Sobhan Parvizi, Hana Mohseni, Mohammad Tarbiat, Behnaz Zolfaghari, Mehrab Mostafaie, Sayyideh Forough Hosseini, Mohammad Ali Shafiee

Hematology, Transfusion and Cell Therapy · 2026-10 · 48 (4) · 106509

DOI: 10.1016/j.htct.2026.106509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-10. Verfasst von Mohammadreza Khosravifarsani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Chronic lymphocytic leukemia shows significant clinical heterogeneity, highlighting the need for reliable, accessible biomarkers for staging and prognosis, especially in resource-limited settings. This study evaluates the association between inflammatory and nutritional biomarkers and clinical stage in newly diagnosed, treatment-naïve patients. METHODS: A cross-sectional study enrolled 150 treatment-naïve chronic lymphocytic leukemia patients and 150 matched healthy controls at outpatient hematology clinics affiliated with Isfahan University of Medical Sciences (2024-2025). Diagnoses followed International Workshop on chronic lymphocytic leukemia 2018 criteria. Controls were confirmed healthy by peripheral blood counts, smear evaluation, and clinical examination. The Rai staging system was used. Serum biomarkers were measured at diagnosis. Statistical analysis included Analysis of Variance and Kruskal-Wallis tests, and Spearman correlation. RESULTS: Elevated ferritin, β2-microglobulin, lactate dehydrogenase and C-reactive protein levels, erythrocyte sedimentation rate, and C-reactive protein-to-albumin ratio correlated significantly with advanced Rai stages (III-IV) (p-value

Schlagwörter

Stichwörter der Autor:innen

Chronic lymphocytic leukemiaInflammatory markersPrognosisRai stage

Autor:innen und Institutionen

  • Department of Oncology, Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Division of General Internal Medicine, Department of Medicine, University Health Network, Toronto General Hospital, Canada.
  • Division of General Internal Medicine, Department of Medicine, University Health Network, Toronto General Hospital, Canada. Electronic address: mohammad.shafiee@uhn.ca.

Zitieren

APA

Khosravifarsani, M., Parvizi, S., Mohseni, H., Tarbiat, M., Zolfaghari, B., Mostafaie, M., Hosseini, S. F., & Shafiee, M. A. (2026). Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy, 48(4), 106509. https://doi.org/10.1016/j.htct.2026.106509

Vancouver

Khosravifarsani M, Parvizi S, Mohseni H, Tarbiat M, Zolfaghari B, Mostafaie M, et al. Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. 2026;48(4):106509. doi:10.1016/j.htct.2026.106509

BibTeX
@article{Khosravifarsani2026,
  author = {Khosravifarsani, Mohammadreza and Parvizi, Sobhan and Mohseni, Hana and Tarbiat, Mohammad and Zolfaghari, Behnaz and Mostafaie, Mehrab and Hosseini, Sayyideh Forough and Shafiee, Mohammad Ali},
  title = {Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {106509},
  doi = {10.1016/j.htct.2026.106509}
}
Kostenlos starten →